NTPC Limited (BOM:532555)

Lumos Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	114,571	8,633	4,657	6,758	9,500
Short-Term Investments	-	500	30,920	17,415	18,745	17,364
Trading Asset Securities	-	-	-	-	-	5,000
Accounts Receivable	-	347,203	445,533	375,025	327,945	316,647
Other Receivables	-	798.5	47,921	50,775	47,726	41,518
Inventory	-	187,223	180,191	142,404	101,393	98,096
Prepaid Expenses	-	-	1,198	1,132	-	-
Restricted Cash	-	-	1,535	55.1	14.7	361.6
Loans Receivable Current	-	2,979	2,711	2,688	2,704	2,591
Other Current Assets	-	277,243	112,891	104,918	77,427	76,309
Total Current Assets	-	930,517	831,533	699,069	582,712	567,387
Property, Plant & Equipment	-	3,717,117	3,465,075	3,295,346	3,159,149	3,006,061
Regulatory Assets	-	187,308	148,560	131,533	131,992	115,533
Other Intangible Assets	-	5,841	906.1	688.2	1,344	1,451
Long-Term Investments	-	196,536	158,349	138,848	106,262	100,893
Long-Term Loans Receivable	-	8,231	5,702	5,538	5,598	5,550
Long-Term Deferred Tax Assets	-	9,443	11,699	9,379	9,957	10,759
Long-Term Accounts Receivable	-	303.6	12,875	28,402	2,819	3,669
Other Long-Term Assets	-	186,349	167,267	170,331	166,131	177,575
Total Assets	-	5,241,646	4,801,966	4,479,133	4,165,964	3,988,876
Accounts Payable	-	111,600	113,380	113,562	112,773	87,263
Accrued Expenses	-	-	69,578	70,097	63,856	54,216
Short-Term Debt	-	-	201,428	144,687	85,711	159,743
Current Portion of Long-Term Debt	-	465,212	247,194	190,477	191,536	128,096
Current Unearned Revenue	-	-	1,114	953	1,118	1,515
Current Portion of Leases	-	3,392	2,529	2,168	1,886	1,618
Current Income Taxes Payable	-	391.5	29.5	864.7	1,411	175
Other Current Liabilities	-	430,136	348,791	335,394	308,426	273,838
Total Current Liabilities	-	1,010,732	984,043	858,201	766,718	706,464
Long-Term Debt	-	2,010,539	1,902,150	1,878,836	1,818,712	1,805,362
Long-Term Leases	-	21,818	18,378	16,040	9,627	7,357
Long-Term Unearned Revenue	-	59,305	54,611	55,624	42,051	42,598
Pension & Post-Retirement Benefits	-	-	9,666	9,660	10,232	10,237
Long-Term Deferred Tax Liabilities	-	189,989	152,318	126,900	109,517	98,878
Other Long-Term Liabilities	-	38,037	29,576	24,334	17,767	25,359
Total Liabilities	-	3,330,419	3,150,743	2,969,596	2,774,623	2,696,255
Common Stock	-	96,967	96,967	96,967	96,967	96,967
Retained Earnings	-	-	1,494,044	1,341,222	1,236,108	1,134,186
Comprehensive Income & Other	-	1,743,745	16,082	32,043	20,663	26,233
Total Common Equity	1,840,712	1,840,712	1,607,093	1,470,232	1,353,737	1,257,385
Minority Interest	-	70,515	44,130	39,305	37,604	35,237
Shareholders' Equity	1,911,227	1,911,227	1,651,223	1,509,536	1,391,342	1,292,622
Total Liabilities & Equity	-	5,241,646	4,801,966	4,479,133	4,165,964	3,988,876
Total Debt	2,500,962	2,500,962	2,371,679	2,232,207	2,107,471	2,102,175
Net Cash (Debt)	-2,385,891	-2,385,891	-2,332,126	-2,210,136	-2,081,969	-2,070,311
Net Cash Per Share	-246.07	-246.10	-240.51	-227.93	-214.71	-210.30
Filing Date Shares Outstanding	9,695	9,696	9,697	9,697	9,697	9,697
Total Common Shares Outstanding	9,695	9,696	9,697	9,697	9,697	9,697
Working Capital	-	-80,215	-152,510	-159,133	-184,006	-139,077
Book Value Per Share	189.85	189.85	165.74	151.62	139.61	129.67
Tangible Book Value	1,834,870	1,834,870	1,606,187	1,469,544	1,352,393	1,255,934
Tangible Book Value Per Share	189.24	189.24	165.64	151.55	139.47	129.52
Land	-	-	121,325	118,629	116,717	114,588
Buildings	-	-	217,476	205,402	192,609	174,130
Machinery	-	-	2,888,729	2,699,073	2,448,920	2,135,167
Construction In Progress	-	-	875,928	891,331	910,252	974,042

Source: S&P Global Market Intelligence. Utility template. Financial Sources.